|
|
|
|
Chronic Myelogenous Leukemia
Cell Genesys to Present Data From Two GVAX(R) Cancer Immunotherapy ... Mar 13, 2006
PR Newswire (press release), ...on June 3, 2006) -- K562/GM-CSF vaccination reduces tumor burden, including achieving molecular remissions in chronic myelogenous leukemia (CML) patients with ...
Bristol-Myers gets review for leukemia drug Mar 7, 2006
NewYorkBusiness.com, Dasatinib is used to treat chronic myelogenous leukemia -- a slow-growing cancer of white blood cells that occurs when the genetic code of some bone marrow ...
FDA Prioritizes Bristol Drug Mar 7, 2006
Red Herring, The Princeton, New Jersey-based company developed the investigational compound to treat two forms of leukemia: chronic myelogenous leukemia, as well as ...
FDA to rule on Bristol's dasatinib in June Mar 7, 2006
BusinessWeek The agency accepted Bristol-Myers' application for the treatment of chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic ...
Bristol-Myers Squibb Says FDA Grants Priority Review For Company's ... Mar 7, 2006
Trading Markets, Dasatinib is indicated to treat chronic myelogenous leukemia, as well as Philadelphia chromosome-positive (PH+ | charts | news | Powerrating) acute ...
BMS cancer drug gets FDA priority review Mar 7, 2006
United Press International BMS is seeking an indication for the compound for the treatment of chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic ...
Hepatitis C Treatment for People With Severe Mental Illness Feb 28, 2006
Psychosomatics (subscription) Guilhot F, Chastang C, Michallet M, et al: Interferon alfa-2B combined with cytarabine versus interferon alone in chronic myelogenous leukemia. ...
FDA Grants Priority Review for Bristol-Myers Squibb's ... Mar 7, 2006
PR Newswire (press release), The NDA seeks approval of dasatinib to treat chronic myelogenous leukemia, as well as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia, in ...
Ernesto Portillo Jr. : 2-nation resident who is claimed by neither ... Mar 1, 2006
Arizona Daily Star, ...cultures. Yet now faced with life-sucking leukemia, he is stuck between both worlds. Lopez, 28, has chronic myelogenous leukemia. He's ...
Reader Responses Feb 22, 2006
New York Times, Indeed. Juvenile Chronic Myelogenous Leukemia (also known as JCML) is what the boy described in the article had. - David Leonhardt. ...
Blake MacDiarmid makes the rounds of political circles Mar 4, 2006
Boca Raton News, ...“I was diagnosed with leukemia,� he said. Specifically, Chronic Myelogenous Leukemia. “I was visiting here for Thanksgiving,� he recalled. ...
Positive Long-Term Outcome Reported for 5-Year Survivors of ... Feb 21, 2006
DG News ...results of the largest study of patient outcomes in allogeneic hemaotopoietic stem cell transplantation (allo-HSCT) for chronic myelogenous leukemia (CML) ever ...
International Approvals: Alertec, Multiferon, Alvesco Feb 27, 2006
Medscape (subscription) ...marketed as an alternative to single-subtype, recombinant alpha-interferons in the treatment of hepatitis B and C, chronic myelogenous leukemia (CML), hairy ...
PDL's Potent Pick-Me-Up Feb 27, 2006
BusinessWeek ...as a conditioning agent to be used in combination with cyclophosphamide prior to blood or marrow transplant in patients with chronic myelogenous leukemia. ...
Cell Genesys Reports Fourth Quarter and Full Year 2005 Results Feb 21, 2006
International News Service, American Society of Hematology meeting in December encouraging clinical data from a Phase 2 trial of GVAX immunotherapy for chronic myelogenous leukemia (CML). ...
Genzyme launches test to monitor Gleevec resistance Feb 13, 2006
News-Medical.net, ...potential treatment of these diseases. Chronic myeloid leukemia is also known as chronic myelogenous leukemia. According to the American ...
Cepheid Initiates CE IVD Products in Europe With Launch of ... Feb 23, 2006
PR Newswire (press release), ...oncologists and labortorians as an aid in the monitoring of BCR-ABL, an abnormal genetic marker found in patients with Chronic Myelogenous Leukemia (CML). ...
Stem cells: A route to cancer's source? Feb 22, 2006
International Herald Tribune, ...it. An amazingly successful anticancer drug is Gleevec, used to treat chronic myelogenous leukemia and three rarer cancers. Many ...
Antigenics Reports Fourth Quarter and Year-End 2005 Financial ... Feb 23, 2006
Genetic Engineering News, ...therapeutic cancer vaccine, in combination with Gleevec(R) (imatinib mesylate, Novartis) for the treatment of chronic myelogenous leukemia patients refractory ...
Power3's Invited Review on Biomarkers and Test for ALS ... Feb 14, 2006
Genetic Engineering News, ...of Parkinson's Disease" and "Biomarkers for Diagnosis and Targeting of Resistance and Sensitivity to Imatinib Mesylate in Chronic Myelogenous Leukemia" will be ...
Health notes Feb 22, 2006
Blue Springs Examiner, 28. This free workshop will provide an overview of chronic myelogenous leukemia and address treatment choices, findings presented at the American Society of ...
Patients turn to Internet to battle illness Feb 26, 2006
Buffalo News, By STEPHEN T. WATSON. When a blood test in 2000 showed he had chronic myelogenous leukemia, Bryce Morgan first called a doctor friend. ...
Acute Graft Versus Host Disease Activity Index Can Be Used to ... Feb 21, 2006
DG News ...severity of GvHD symptoms and abnormalities, use of immunosuppressive drugs, and performance status in 386 patients with chronic myelogenous leukemia (CML) who ...
CEPHEID LAUNCHES NEW PRODUCTS IN EUROPE Feb 23, 2006
Small Times The Xpert BCR-ABL Monitor can be used as an aid in the monitoring of BCR-ABL, an abnormal genetic marker found in patients with chronic myelogenous leukemia.
First Responders Select GeneXpert System for Biothreat Detection Feb 16, 2006
International News Service, For research use only, the product identifies the BCR- ABL chromosomal translocation associated with Chronic Myelogenous Leukemia in the clinical research ...
Hull's e-mails reveal relationship Feb 15, 2006
Topics.com, He also offered to resign citing medical reasons. Howard Hull, who's battled chronic myelogenous leukemia, underwent a bone-marrow transplant in 1991. ...
New Hope For Stomach Cancer Feb 24, 2006
WFtv.com, The drug Gleevec, originally used to treat patients with chronic myelogenous leukemia, has also been useful in the treatment of this disease. ...
Our towns - news from our local communities Feb 12, 2006
Lansing State Journal, Rocky, 37, is being treated for chronic myelogenous leukemia, and Tammy, 26, is being treated for stage-four breast cancer that also involves her lymph nodes. ...
Iron Imports. V. Transport of iron through the intestinal ... Feb 14, 2006
AJP-Gastrointestinal & Liver Physiology (subscription) ...postulated to be a transporter of ferric iron in human and rat enterocytes and in K562 cells, a cell line derived from chronic myelogenous leukemia that can be ...
SGX Pharmaceuticals Presenting Data at Keystone Symposia Feb 15, 2006
PharmaLive.com (press release), The clinical success of Gleevec has demonstrated that BCR-ABL kinase inhibitors can provide effective treatment of Chronic Myelogenous Leukemia (CML). ...
Kosan Initiates Phase I Clinical Trial of Oral Hsp90 Inhibitor KOS ... 25 Jan 2006
Yahoo! News (press release) Drug Administration and the European Medicines Agency for the treatment of multiple myeloma as well as another hematologic cancer, chronic myelogenous leukemia ...
Bristol-Myers Squibb Company Reports Financial Results for the ... 25 Jan 2006
PR Newswire (press release), ...of its New Drug Application (NDA) to the FDA for dasatinib, a SRC/ABL Kinase Inhibitor for the potential treatment of chronic myelogenous leukemia (CML). ...
Leukemia's pedaling foe Jan 22, 2006
Charlotte Observer, ...school together. In 1993, Jones was diagnosed with chronic myelogenous leukemia, a rare cancer of the bone marrow. Her situation ...
HHMI: Howard Hughes Medical Institute: Studies Reveal How New Drug ... Jan 23, 2006
Webbolt Business News (subscription), HHMI researchers have discovered how a new generation of drugs thwarts a deadly mutation that causes chronic myelogenous leukemia (CML). ...
ChemGenex Granted US Patent on Ceflatonin(R)'s Use for Treatment ... Jan 17, 2006
Yahoo! News (press release) The patent is entitled "Treatment of chronic myelogenous leukemia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other ...
Cancer patients find relief in specialized massage Jan 22, 2006
Anchorage Daily News, When she was pregnant with her second child, she was diagnosed with chronic myelogenous leukemia, a blood cancer, in February 2002. ...
(BW) Power3 Medical Products Updates IP Position Jan 18, 2006
Houston Chronicle, ...of Parkinson's Disease" and "Biomarkers for Diagnosis and Targeting of Resistance and Sensitivity to Imatinib Mesylate in Chronic Myelogenous Leukemia" will be ...
INNOVIVE Pharmaceuticals Licenses Potent Dual Bcr-Abl/Lyn Kinase ... Jan 5, 2006
Business Wire (press release), INNOVIVE will develop NS-187 for the treatment of chronic myelogenous leukemia (CML) and anticipates commencing Phase I trials this year. ...
Allosteric inhibitors of Bcr-abl–dependent cell proliferation Jan 20, 2006
Nature.com (subscription), Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized at the molecular level by the expression of Bcr-abl, a 210-kDa fusion protein ...
Roche developing next-generation Fuzeon Jan 18, 2006
Science Daily (press release) BMS' dasatinib expected to rival Gleevec (November 21, 2005) -- An analyst firm predicts Bristol Myers Squibb's chronic myelogenous leukemia drug dasatinib ...
Mom, Wife Loses Battle With Leukemia Jan 4, 2006
Tampa Tribune, She was 27. She and her husband, Kenny, had been married only two months when she was diagnosed with chronic myelogenous leukemia in June 2004. ...
Helping Amy helps others who need cells Jan 12, 2006
Pittsburgh Post Gazette, An eighth-grader at Jefferson Middle School in Mt. Lebanon, Amy was diagnosed with chronic myelogenous leukemia in autumn 2003. ...
Bristol-Myers Squibb Submits New Drug Application for Dasatinib Dec 28, 2005
Finanzen.net, ...rolling submission of its New Drug Application (NDA) to the US Food and Drug Administration (FDA) for dasatinib to treat chronic myelogenous leukemia (CML) in ...
INNOVIVE Pharmaceuticals Licenses WT1 Peptide Cancer ... Jan 9, 2006
Genetic Engineering News, ...known as NS-187) is an orally bioavailable, rationally designed, dual Bcr-Abl and Lyn-kinase inhibitor for the treatment of chronic myelogenous leukemia (CML). ...
Finding cancer's Achilles' heels Dec 27, 2005
International Herald Tribune, Jay Weinstein found out that he had chronic myelogenous leukemia in 1996, two weeks before his marriage. He was 36 and he thought his health was great. ...
Protein Design Labs Becomes PDL BioPharma Jan 9, 2006
MSN Money ...infarction (AMI), and IV Busulfex(R) (busulfan), a pre-conditioning agent used in connection with bone marrow transplantation in chronic myelogenous leukemia. ...
Breaking the cancer code Jan 1, 2006
DetNews.com, ...the cancer spread. Jay Weinstein found out he had chronic myelogenous leukemia in 1996, two weeks before his marriage. He was 36 ...
Slowly, Cancer Genes Tender Their Secrets Dec 28, 2005
Spartanburg Herald Journal (subscription), By GINA KOLATA. Jay Weinstein found out that he had chronic myelogenous leukemia in 1996, two weeks before his marriage. He was a ...
Slowly, Cancer Genes Tender Their Secrets Dec 26, 2005
New York Times, Jay Weinstein found out that he had chronic myelogenous leukemia in 1996, two weeks before his marriage. A cervical carcinoma cell ...
Nippon Shinyaku, INNOVIVE Pharmaceuticals Conclude Licensing ... Jan 6, 2006
Japan Corporate News (press release), NS-187, which is a molecular targeted agent in the preclinical stage, is intended for the treatment of chronic myelogenous leukemia (CML). ...
Pfizer, Perlegen Announce New Collaboration and Bristol-Myers ... Dec 29, 2005
Financial News USA (press release), The pharmaceutical and health-care products company said it completed the rolling submission for Dasatinib to treat chronic myelogenous leukemia in different ...
Paper in Cancer Research Further Validates Ambit Biosciences' ... Jan 16, 2006
Business Wire (press release), The T315I mutation is the most common drug-resistant mutation in chronic myelogenous leukemia (CML) and confers resistance not only to Gleevec, but to all ...
Drug maker to help woman Jan 6, 2006
Modesto Bee, ...maker of Gleevec. The drug has been successful in controlling chronic myelogenous leukemia and a form of gastric cancer. Gregory, 69 ...
Carlos continues to give through bracelet sales Dec 28, 2005
Tucson Citizen, Carlos would have been a junior at Salpointe Catholic High School. He was diagnosed with chronic myelogenous leukemia, a blood cancer, in November 2000. ...
Desatinib Promising for Patients with CML Who Do Not Respond to ... Dec 23, 2005
Cancer Consultants (press release), ...novel agent desatinib (BM-354825), which is still in clinical trials, is an effective treatment option for patients with chronic myelogenous leukemia (CML) who ...
Bristol-Myers completes dasatinib FDA application Dec 28, 2005
Reuters Research)on Wednesday said it had completed an application to the US Food and Drug Administration for dasatinib as a treatment for chronic myelogenous leukemia ...
Cancer researchers hopeful of new way to fight the disease Dec 27, 2005
Seattle Post Intelligencer By GINA KOLATA. Jay Weinstein found out that he had chronic myelogenous leukemia in 1996, two weeks before his marriage. The 36-year ...
Cancer as killer may become a thing of the past Dec 27, 2005
Salt Lake Tribune, By Gina Kolata. Jay Weinstein found out that he had chronic myelogenous leukemia in 1996, two weeks before his marriage. The New York City firefighter was 36. ...
Randle's comeback tops list of Courier stories Jan 5, 2006
Ceres Courier, School on Feb. 21. The popular Ceres High senior was diagnosed with chronic myelogenous leukemia (CML) on Feb. 17. Randle's cancer ...
Discomfort no problem to save a life Jan 8, 2006
NewsOK.com (subscription), It was a perfect match, I'm told. And Friday, I met her -- a 12-year-old girl with chronic myelogenous leukemia who lives somewhere in Europe. ...
Stem cells a Christmas gift Dec 23, 2005
Wilson Daily Times (subscription), Warenda left Wilson Monday for Richmond and underwent the donation procedure Tuesday. The woman she's helping has chronic myelogenous leukemia. ...
IMPAC Announces Automated Solution Update to Support 2006 CMS ... Dec 22, 2005
PR Newswire (press release), ...and management (E & M) visits for established cancer patients who have one of 13 target cancers (breast cancer, chronic myelogenous leukemia, colon cancer ...
Time In - Katie Knudson Dec 20, 2005
U.S. National Soccer Players, By the time they had Katie's fever under control and were ready to send her home, they also had a diagnosis - Chronic Myelogenous Leukemia (CML), a type of ...
Researchers Closer to Understanding How One Mutation Causes Three ... Dec 19, 2005
Howard Hughes Medical Institute, ...“Although relatively rare individually, together these disorders are about five times more common than chronic myelogenous leukemia.�. ...
Silent Night, holy night, all is calm, all is bright… Dec 20, 2005
HoweStreet.com, ...well. Chronic myelogenous leukemia (CML) may benefit from the root of a common ornamental plant known as coleus forskohili. The ...
Backyard Garden May Yield Leukemia Treatment Dec 9, 2005
Science Daily (press release) Scientists here have identified a new pathway in the progression of chronic myelogenous leukemia (CML). They also discovered that ...
Cell Genesys Reports Positive Results From Phase 2 Trial of GVAX(R ... Dec 12, 2005
PR Newswire (press release), ...(Nasdaq: CEGE) today reported encouraging clinical data from a Phase 2 trial of GVAX(R) vaccine for chronic myelogenous leukemia (CML). ...
Dacogen(TM) (Decitabine) Injection Data Presented at American ... Dec 12, 2005
Genetic Engineering News, Data from a phase 2 study of Dacogen injection in combination with imatinib in patients with chronic myelogenous leukemia (CML) were presented in a poster ...
Dacogen(TM) (Decitabine) Injection Complete Response Accepted for ... Dec 15, 2005
Genetic Engineering News, ...currently being evaluated in a broad clinical development program in patients with MDS, acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), and ...
Cell Genesys says Phase 2 trail for leukemia vaccine positive Dec 12, 2005
Reuters ...(CEGE.O: Quote, Profile, Research) on Monday said results from its Phase 2 trial of a vaccine for chronic myelogenous leukemia, GVAX, is encouraging. ...
ChemGenex Reports Compelling Phase 2 Data Published In Leading ... Dec 11, 2005
PR Newswire (press release), ...(1) Abstract 4839, entitled "Subcutaneous (SC) Homoharringtonine (HHT) for Patients with Chronic Myelogenous Leukemia (CML) in Chronic Phase after Imatinib ...
Common garden plant may hold cure for leukemia Dec 12, 2005
News-Medical.net, Scientists in the US believe they have identified a new pathway in the progression of chronic myelogenous leukemia (CML). They have ...
Dacogen(TM) (Decitabine) Injection Data Presented at American ... Dec 12, 2005
PR Newswire (press release), Imatinib in CML Patients Data from a phase 2 study of Dacogen injection in combination with imatinib in patients with chronic myelogenous leukemia (CML) were ...
SGX Pharmaceuticals Presenting Data at American Society of ... Dec 13, 2005
Yahoo! News (press release) The clinical success of Gleevec has demonstrated that BCR-ABL kinase inhibitors can provide effective treatment of Chronic Myelogenous Leukemia (CML). ...
Cell Genesys Posts Positive Study Data Dec 12, 2005
MSN Money All patients in the nine-week study had chronic myelogenous leukemia whose disease had persisted despite more than one year on another drug, Novartis AG's ...
Philip J. Fialkow, MD and Helen Fialkow found dead in Nepal on Nov ... Nov 30, 2005
uwnews.org, ...proof that a common lympho-hematopoietic stem cell exists in humans, and the first evidence for the multistep pathogenesis of chronic myelogenous leukemia. ...
AstraZeneca's Casodex may get boost Dec 8, 2005
Science Daily (press release) BMS' dasatinib expected to rival Gleevec (November 21, 2005) -- An analyst firm predicts Bristol Myers Squibb's chronic myelogenous leukemia drug dasatinib ...
Kosan Initiates Phase II Clinical Trial of KOS-953 in Combination ... Dec 8, 2005
PR Newswire (press release), FDA) and the European Medicines Agency (EMEA) for the treatment of multiple myeloma as well as another hematologic cancer, chronic myelogenous leukemia. ...
CML Vaccine Gives Uneven Results in Control of Residual Disease Dec 13, 2005
Cancerpage.com, NEW YORK DEC 12, 2005 (Reuters Health) - A vaccine against chronic myelogenous leukemia (CML) has resulted in a molecular response, to varying degrees, in most ...
Trials help patients get new treatments Dec 11, 2005
The Jackson Citizen-Patriot, ...patient who comes immediately to Clark's mind is Beth Hagaman of Leoni Township, who was diagnosed a decade ago with chronic myelogenous leukemia (see article ...
Discoveries Reveal Gene Mutation That Causes Blood Disorders Dec 11, 2005
PR Newswire (press release), Abnormal regulation or function of tyrosine kinases have been implicated in many cancers, including chronic myelogenous leukemia (CML), the treatment of which ...
It's a sad journey along a fast road to see our parents Dec 11, 2005
Richmond Times Dispatch, ...offered. My father had chronic myelogenous leukemia, and he was experiencing a blast crisis, the final stages of the disease. Then ...
BMS' dasatinib expected to rival Gleevec Nov 21, 2005
Science Daily (press release) 21 (UPI) -- An analyst firm predicts Bristol Myers Squibb's chronic myelogenous leukemia drug dasatinib, which is currently in phase 2 trials, could be as ...
Health calendar and support groups Nov 27, 2005
OCRegister, ...(714) 633-6858. Chronic Myelogenous Leukemia. 6:30-8 pm second Monday. Hoag Memorial Hospital Presbyterian, One Hoag Drive, Cancer Center, Newport Beach. ...
Writer has strange encounter of the meaningful kind Dec 4, 2005
Richmond Times Dispatch, Of course, I knew the answer to that one. Leukemia. Chronic myelogenous leukemia. I think about my father often, but not in ways you might suspect. ...
A Thanksgiving worth cheering for Nov 23, 2005
Columbia Falls Hungry Horse News, And that's saying something. Two years ago Dunlap was diagnosed with chronic myelogenous leukemia. She was 15 and a sophomore at the time. ...
BMS` dasatinib expected to rival Gleevec Nov 21, 2005
Monsters and Critics.com, WASHINGTON, DC, United States (UPI) -- An analyst firm predicts Bristol Myers Squibb`s chronic myelogenous leukemia drug dasatinib, which is currently in phase ...
Connecticut girl waiting for marrow donor Nov 11, 2005
WFSB, ..."I can't ride anymore because I'm not supposed to be around animals while I have this disease." Hailey has chronic myelogenous leukemia. "It's overwhelming. ...
Koch Award Given To Pioneer Of Leukemia Research Oct 28, 2005
All Headline News Brian J. Druker the2005 Robert Koch Prize for his pioneering discoveries concerning the development and therapy of chronic myelogenous leukemia, a type of ...
Leukemia Under the Microscope Nov 2, 2005
Daily Californian, The main types of leukemia include acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myelogenous leukemia. ...
Marrow Recipient Meets Donor During Ceremony Celebrating 25,000 ... Nov 6, 2005
PR Newswire (press release), ...the Registry to help save lives." In 1986, Richard Tate, a 21-year Postal employee from Wilmington, DE, was diagnosed with chronic myelogenous leukemia, a slow ...
Marrow Recipient Meets Donor During Ceremony Celebrating 25,000 ... Nov 6, 2005
PR Newswire (press release), In 1986, Richard Tate, a 21-year Postal employee from Wilmington, DE, was diagnosed with chronic myelogenous leukemia, a slow-growing cancer of the white blood ...
Health calendar Oct 31, 2005
Austin American-Statesman (subscription), The Leukemia and Lymphoma Society offers an education program 'Chronic Myelogenous Leukemia: Issues and Insights.' Dave and Buster's, 9333 Research Blvd. Free. ...
Cell Genesys Reports Third Quarter 2005 Financial Results Nov 2, 2005
Yahoo! News (press release) In addition, initial results from a Phase 2 trial of GVAX® vaccine for leukemia in patients with chronic myelogenous leukemia (CML) will be presented at the ...
Conference examines role of chromosome changes in cancer Oct 29, 2005
Medical News Today (press release), Later that same year, she found that something similar happened in patients with chronic myelogenous leukemia; a crucial segment of chromosome 22 broke off and ...
Phase II Study Suggests Gleevec® Is Safe and Effective for ... Oct 25, 2005
Cancer Consultants (press release), After Treatment With Imatinib-Mesylate in Patients With Failure After Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia: Results of a ...
Robert Koch Prize and Gold Medal Awarded Oct 28, 2005
PR Newswire (press release), He receives the prize for his pioneering discoveries concerning the development and therapy of chronic myelogenous leukemia, a type of blood cancer. ...
Gene arrangements cause most cases of prostate cancer Oct 29, 2005
Food Consumer, The resulting BCR-ABL fusion gene causes the development of chronic myelogenous leukemia, according to the National Cancer Institute. ...
Cell Genesys Confirms Upcoming Clinical Data Presentations for Two ... Oct 20, 2005
PR Newswire (press release), Society of Hematology (ASH) meeting in Atlanta, GA, December 12, 2005 Phase 2 Trial of GVAX(R) Leukemia Vaccine in Chronic Myelogenous Leukemia In other news ...
Fused genes trigger the development of prostate cancer Nov 1, 2005
Xagena.it, ...involved in prostate cancer, which would be analogous to Imatinib - a drug designed to target the BCR-ABL gene fusion that causes chronic myelogenous leukemia.
Group seeks bone marrow match Oct 20, 2005
Gateway Newspapers Amy was diagnosed with chronic myelogenous leukemia, a type that is rare for a child her age. The only known cure is a stem cell transplant. ...
'Amy's Army' Enlists Volunteers, Potential Donors Oct 23, 2005
KDKA, Bone Marrow Registry, although they have not yet found a match for 13-year-old Amy Katz, who was diagnosed with Chronic Myelogenous Leukemia in 2003.
NCCN Releases Updated Treatment Guidelines for Non-Small Cell Lung ... Oct 27, 2005
Business Wire (press release), Other recently updated NCCN guidelines include those for Acute Myeloid Leukemia (AML), Bone Cancer and Chronic Myelogenous Leukemia (CML). ...
American Honored For Cancer Research Oct 28, 2005
All Headline News J. Druker is awarded the 2005 Robert Koch Prize for his pioneering discoveries concerning the development and therapy of chronic myelogenous leukemia, a type ...
As RNAi Technology Progresses Companies Try to Increase Their ... Nov 3, 2005
Genetic Engineering News, ...of RNAi are considered, in particular, the prospects of improving on existing treatment modalities for some cancers such as chronic myelogenous leukemia. ...
Gleevec® Effective for Molecular and Cytogenetic Relapses ... Oct 26, 2005
Cancer Consultants (press release), ...after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: Results of a ...
OHSU professor receives major honor in Germany Oct 28, 2005
Portland Business Journal, ...in Berlin said Friday Druker earned the honor for for his pioneering discoveries concerning the development and therapy of chronic myelogenous leukemia, a type ...
Bristol-Myers Squibb Company Reports Financial Results for the ... Oct 28, 2005
PR Newswire (press release), Squibb plans to present Phase II data on dasatinib, a SRC/ABL Kinase Inhibitor being investigated for the treatment of chronic myelogenous leukemia (CML), at ...
New prostate cancer clue Oct 28, 2005
Newsday, The discovery that gene fusion is at the heart of chronic myelogenous leukemia, a disorder known as CML in which the body produces cancerous white blood cells ...
Researchers Use New Method to Discover Gene Rearrangements That ... Oct 27, 2005
National Institutes of Health (press release) ...the ABL gene. The resulting BCR-ABL fusion gene causes the development of chronic myelogenous leukemia. Epithelial tumors, such ...
Prostate cancer tied to genes Oct 28, 2005
Fort Lauderdale Sun Sentinel, If successful, it could be similar to Gleevec, which interferes with the workings of a fused gene that causes chronic myelogenous leukemia. ...
Cytokinetics, Incorporated Reports Third Quarter 2005 Financial ... Oct 26, 2005
Yahoo! News (press release) ...failed to respond to all standard therapies and the other clinical trial is enrolling patients with acute leukemia, chronic myelogenous leukemia or advanced ...
SouthScape: A weekly roundup of things to do in South communities Oct 27, 2005
Pittsburgh Post Gazette, ...of Mt. Lebanon, who has chronic myelogenous leukemia, will sponsor a blood and bone marrow drive, 9 am-3 pm Nov. 6, Mt. Lebanon ...
Project Life promotes bone marrow typing Oct 21, 2005
The North Carolina State Technician, Alex Sibley, a graduate student in operations research, is a survivor because of a bone marrow transplant. "I had chronic myelogenous leukemia when I was 15. ...
Fused genes may trigger prostate cancer Oct 28, 2005
Cancerfacts.com, ...research led to the development of the leukemia pill, Gleevec®, a drug designed to target the BCR-ABL gene fusion that causes chronic myelogenous leukemia. ...
Beating the Clock Oct 15, 2005
Bremerton Sun (subscription), The first time, a pastor in Kansas City gave her some of his own bone marrow when she was battling the potentially fatal chronic myelogenous leukemia. ...
Clinical Trial Patients Spread the Word: Hope Oct 14, 2005
CancerWise Siegel was diagnosed with chronic myelogenous leukemia (CML) in April 1995 and given a 50% chance of survival with standard cancer treatments. ...
CEPHEID LAUNCHES GENEXPERT IN MOLECULAR CLINICAL RESEARCH Oct 26, 2005
Small Times The BCR/ABL product is part of a broader program directed at investigating its potential use for monitoring patients with chronic myelogenous leukemia. ...
Cepheid Launches GeneXpert(R) System in the Molecular Clinical ... Oct 26, 2005
Yahoo! News (press release) The BCR/ABL product is part of a broader program directed at investigating its potential use for monitoring patients with Chronic Myelogenous Leukemia (CML). ...
Hemosol Provides Corporate Update Oct 21, 2005
Canada NewsWire (press release), ...loss; Drug Delivery for the treatment of Hepatitis C and liver cancer; and Cell Therapeutics for the treatment of chronic myelogenous leukemia and chemotherapy ...
Antigenics Reports Third Quarter 2005 Financial Results and Recent ... Oct 27, 2005
Business Wire (press release), ...therapeutic cancer vaccine, in combination with Gleevec(R) (imatinib mesylate, Novartis), for the treatment of chronic myelogenous leukemia (CML) patients ...
Three new genetic mutations in brain tumors identified Oct 23, 2005
Xagena.it, ...have been implicated in several other cancers such as colorectal, breast and ovarian cancer, as well as chronic myelogenous leukemia, gastrointestinal stromal ...
Bristol-Myers Ties Revival Hopes to 3 New Drugs (Update3) 10 Sep 2005
...is seeking approval for dasatinib, which has yet to receive a brand name, for the treatment of a type of blood cancer called chronic myelogenous leukemia. ... Bloomberg
Health calendar 10 Sep 2005
Twice a month. MOMS Resource Center, 1212 N. Broadway St., Suite 150, Santa Ana. (714) 972-2610. Chronic Myelogenous Leukemia. 6:30-8 pm second Monday. ... OCRegister (subscription),
Bay Area Extra Sep 9, 2005
She is battling chronic myelogenous leukemia. Both women need marrow transplants, and the most likely match will be with a Latino donor. ... San Jose Mercury News,
Golf tournament to benefit disease research Sep 9, 2005
The golf tournament raises funds for other myeloproliferative disorders, such as polycythemia vera, chronic myelogenous leukemia and myelofibrosis. ... Bethel Beacon,
Local Medical Team Develops Effective Leukemia Treatment Aug 30, 2005
...therapy by prescribing existing leukemia medicine, such as vincristine and daunorubicin, together with Glivec, a medicine for chronic myelogenous leukemia. ... Korea Times,
Pretreated Bone Marrow Grafts Don't Lower GvHD Risk Aug 26, 2005
The diagnoses included chronic myelogenous leukemia, acute myelogenous leukemia, biphenotypic leukemia, juvenile myelomonocytic leukemia, myelodysplastic ... MedPage Today,
Leukemia treatment raises survival rate Aug 30, 2005
...imatinib from 1995 to 2001. Imatinib is the standard treatment for chronic myelogenous leukemia. According to Professor Lee's journal ... Korea Herald (subscription),
Structural GenomiX Initiates Phase 2/3 Trial of Troxatyl for the ... Aug 16, 2005
Promising early clinical results were observed in AML, myelodysplastic syndromes, blast phase chronic myelogenous leukemia, renal cell carcinoma, and ... PR Newswire (press release),
Largest Study Of Unrelated Bone Marrow Transplantation For ... Aug 15, 2005
...a higher risk of viral infection in general and higher risk of disease recurrence specifically in patients with chronic myelogenous leukemia, eliminated the ... Science Daily (press release)
Jones: I will try to keep positive Aug 22, 2005
AUBURN - When Mona Lisa Newman Jones was diagnosed with chronic myelogenous leukemia just four months back, her family rallied to help in any way that they ... Auburn Citizen,
Mother, daughter to walk in memory of family members Aug 22, 2005
Society helped finance the development of a new drug called Gleevec which can normalize white blood cells in cancer patients with chronic myelogenous leukemia. ... Muscatine Journal,
Scientists discover breast cancer pathway Aug 10, 2005
Gleevec blocks uncontrolled growth signals in Chronic Myelogenous Leukemia and Gastrointestinal Stromal Tumour, targeting c-Kit kinase, along with another ... Drug Researcher.com,
Hemosol Announces Second Quarter Financial Results Aug 12, 2005
...loss; Drug Delivery for the treatment of Hepatitis C and liver cancer; and Cell Therapeutics for the treatment of chronic myelogenous leukemia and chemotherapy ... CNW Telbec (Communiqués de presse),
Genentech Tops 2005 Pharma Achievement Awards Aug 17, 2005
For all the remarkable success of Gleevec, the Novartis drug that targets the BCR-ABL oncoprotein in chronic myelogenous leukemia, patients often develop ... Health-IT World,
Naked ladies raise funds for cancer Aug 24, 2005
Their keyboardist, Kevin Hearn, was diagnosed with chronic myelogenous leukemia, a form of blood cancer in 1998, and had to take two years off to receive ... Excalibur Online,
Light The Night Walks Raise Funds For Blood Cancer -- 16 Sep 2005
...cholesterol. He did a series of blood work and I found out by happenstance I had chronic myelogenous leukemia," Schrader said. CML ... / NBC 10.com,
| |
